Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 1998

View Archived Issues

Reduced incidence of death following hirudin/streptokinase therapy for acute myocardial infarction

Rabeprazole and teprenone combination therapy effective for gastric ulcers

Y-128 is effective in improving diabetic peripheral nerve disorder

Betaine-containing toothpaste relieves chronic dry mouth symptoms

BTG offers novel iron complexes for licensing

Wyeth-Ayerst and Scios terminate North American trial of Fiblast and continue European trial

Therapeutic Antibodies announces new development strategy for CytoTAb

Phase II trial of Incel for blocking MDR in previously untreated prostate cancer patients

Ibex suspends phase III trial of Neutralase pending further analysis of data

Team at Kyowa Hakko presents new antitumor series

ET-A receptor antagonists for peripheral circulatory disorders, atherosclerosis

Inhibitors of sPLA2 described by Lilly for septic shock, etc.

Takeda patents tachykinin antagonists and their use in urinary disorders

Celgene reports encouraging results from AIDS wasting study with Thalomid

Dura: Q2 1998 highlights

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...